A New Era—Leveraging RDNs in Medication Management in Reducing Therapeutic Inertia
Despite advances in available treatments and evidence-based clinical practice guidelines, fewer than one in four diabetes patients are successfully achieving metabolic targets—a statistic that has remained unchanged since 2005. It’s critical to avoid therapeutic inertia and prioritize timely and appropriate intensification of lifestyle and/or pharmacologic therapy for patients who have not achieved the recommended targets, yet challenges remain. While there are multiple factors that may contribute to therapeutic inertia, one contributing factor is that primary care physicians face significant time constraints, and achieving optimal patient care often requires frequent visits, medication adjustments, and ongoing support for making lifestyle changes. Especially in rural areas, there is a growing physician shortage. In the presentation A New Era—Leveraging RDNs in Medication Management in Reducing Therapeutic Inertia, Gretchen Benson, RDN, CDCES, discusses how a team-based approach that utilizes an expanded role for registered dietitian nutritionists (RDNs) can help patients with type 2 diabetes, hypertension, and hyperlipidemia achieve improved outcomes. This presentation highlights results from several studies that have shown successful clinical outcomes from a collaborative, team-based approach that expands the RDN role in initiating/titrating medications. It also shares steps to implementing a successful medication protocol.
Note: More than 45 presenters submitted articles previewing their Virtual 80th Scientific Sessions presentations. View all Presenter Perspectives
VIEW THIS PRESENTATION
Already registered?
View this presentation at ADA2020.org
Not yet registered?
Register now to access all presentations from the Virtual 80th Scientific Sessions